Skip to main content

Malignant Hyperthermia in Dogs

  • Conference paper
  • 78 Accesses

Abstract

Our knowledge and understanding of the pharmacogenetic disease malignant hyperthermia (MH) has been significantly advanced through investigations of the porcine animal model. The distinction between “trigger” and “safe” anesthetics for MH-susceptible (MHS) human patients was originally based on the results of testing these drugs in the MHS pig [1,2]. The efficacy of dantrolene sodium for treating and preventing MH was discovered by Harrison [3] via experiments with MH pigs. Subsequent to its discovery in pigs, MHS was reported to occur in other species including the dog [4], cat [5], and horse [6]. Because MH in man represents a spectrum of susceptibility [7] and is genetically heterogenous [8], thorough investigations of MH among different animal species may provide important genetic and epigenetic information that will further advance our understanding of MH in man. In this chapter, I attempt to document the current state of knowledge regarding MH in dogs, focusing on the interesting genetic and phenotypic differences between MH in dogs and in pigs and how understanding the basis for these differences may have an impact on our understanding of MH in man.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hall LW, Trim CM, Woolf N (1972) Further studies of porcine malignant hyperthermia. Br Med J 2: 145–148

    Article  PubMed  CAS  Google Scholar 

  2. Harrison GG, Saunders SJ, Biebuyck JF, Hickman R, Dent DM, Weaver V, Terblanche J (1969) Anaesthetic-induced malignant hyperpyrexia and a method for its prediction. Br J Anaesth 41: 844–854

    Article  PubMed  CAS  Google Scholar 

  3. Harrison GG (1975) Control of the malignant hyperpyretic syndrome in MHS swine by dantrolene sodium. Br J Anaesth 47: 62–65

    Article  PubMed  CAS  Google Scholar 

  4. Short CE, Paddleford RR (1973) Malignant hyperthermia in the dog. Anesthesiology 39: 462–463

    Article  PubMed  CAS  Google Scholar 

  5. De Jong RH, Hoarner JE, Amory DW (1974) Malignant hyperthermia in the cat. Anesthesiology 41: 608–609

    Article  PubMed  Google Scholar 

  6. McClure JJ (1975) Malignant hyperthermia in the horse. Minn Vet 15: 11–12

    Google Scholar 

  7. Nelson TE, Flewellen EH, Gloyna DF (1983) Spectrum of susceptibility of malignant hyperthermia: diagnostic dilemma. Anesth Analg 62: 545–552

    Article  PubMed  CAS  Google Scholar 

  8. Levitt RC, Nouri N, Jedlicka AE, McKusick VA, Marks AR, Shuttack JG, Fletcher JE, Rosenberg H, Meyers DA (1991) Evidence for genetic heterogeneity in malignant hyperthermia. Genomics 11: 543–547

    Article  PubMed  CAS  Google Scholar 

  9. Bagshaw RJ, Cox RH, Knight DH, et al (1978) Malignant hyperthermia in a greyhound.

    Google Scholar 

  10. Kirmayer AH, Klide AM, Purvance JE (1984) Malignant hyperthermia in a dog: case report and review of the syndrome. J Am Vet Med Assoc 185: 978–982

    PubMed  CAS  Google Scholar 

  11. Leary SL, Anderson LC, Manning PJ, et al (1983) Recurrent malignant hyperthermia in a greyhound. J Am Vet Med Assoc 182: 521–522

    PubMed  CAS  Google Scholar 

  12. O’Brien PI, Cribb PH, White RJ, et al (1983) Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony. Can Vet J 24: 172–177

    PubMed  Google Scholar 

  13. Rand JS, O’Brien P (1987) Exercise-induced malignant hyperthermia in an English springer spaniel. J Am Vet Med Assoc 190: 1013–1014

    PubMed  CAS  Google Scholar 

  14. Nelson TE (1991) Malignant hyperthermia in dogs. J Am Vet Med Assoc 198: 989–994

    PubMed  CAS  Google Scholar 

  15. Britt BA, Kalow W (1970) Malignant hyperthermia: a statistical review. Can Anaesth Soc J 17: 293–315

    Article  PubMed  CAS  Google Scholar 

  16. Nelson TE (1993) Pharmacogenetics and malignant hyperthermia. Anaesth Pharmacol Rev 1: 362–376

    CAS  Google Scholar 

  17. Nelson TE (1990) Porcine malignant hyperthermia: critical temperatures for in vivo and in vitro responses. Anesthesiology 73: 449–454

    Article  PubMed  CAS  Google Scholar 

  18. Nelson TE (1987) Skeletal muscle sarcoplasmic reticulum in the malignant hyperthermia syndrome. In: Britt BA (ed) Malignant hyperthermia. Nijhoff, Boston, pp 4378

    Google Scholar 

  19. Jenden DJ, Fairhurst AS (1969) The pharmacology of ryanodine. Pharmacol Rev 21: 124

    Google Scholar 

  20. Chu AM, Diaz-Munoz M, Hawkes MJ, Brush K, Hamilton SL (1990) Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel. Mol Pharmacol 37: 735–741

    PubMed  CAS  Google Scholar 

  21. Fujii J, Otsu K, Zarzato S, de Leon VK, Khanna JE, Weiler JE, O’Brien PJ, MacLennan DH (1991) Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253: 448–451

    Article  PubMed  CAS  Google Scholar 

  22. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, Frodis W, Britt BA, Worton RG (1990) Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 343: 559–561

    Article  PubMed  CAS  Google Scholar 

  23. McPherson PS, Campbell KP (1993) The ryanodine receptor/calcium release channel. J Biol Chem 268: 13675–13678

    Google Scholar 

  24. Nelson TE, Sweo T (1988) Ca“ uptake and Ca” release by skeletal muscle sarcoplasmic reticulum: differing sensitivity to inhalational anesthetics. Anesthesiology 69: 571577

    Google Scholar 

  25. Louis CF, Zualkernan K, Roghair T, Mickelson JR (1992) The effects of volatile anesthetics on calcium regulation by malignant hyperthermia-susceptible sarcoplasmic reticulum. Anesthesiology 77: 114–125

    Article  PubMed  CAS  Google Scholar 

  26. Nelson TE, Nelson KE (1990) Intra-and extrahumenal sarcoplasmic reticulum regulatory sites for Ca“-induced Ca” release. FEBS Lett 263: 292–294

    Article  PubMed  CAS  Google Scholar 

  27. Nelson TE (1983) Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. J Clin Invest 72: 862–870

    Article  PubMed  CAS  Google Scholar 

  28. Nelson TE, Levin M, Volpe P (1991) Evidence for intraluminal Ca“ regulatory site defect in sarcoplasmic reticulum from malignant hyperthermia pig muscle. J Pharmacol Exp Ther 256: 645–649

    PubMed  CAS  Google Scholar 

  29. MacLennan DH, Phillips MS (1992) Malignant hyperthermia. Science 256: 789–794

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Tokyo

About this paper

Cite this paper

Nelson, T.E. (1996). Malignant Hyperthermia in Dogs. In: Morio, M., Kikuchi, H., Yuge, O. (eds) Malignant Hyperthermia. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68346-9_23

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68346-9_23

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68348-3

  • Online ISBN: 978-4-431-68346-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics